TruthArchive.ai - Related Video Feed

Johnson and Johnson developed Risperdal for schizophrenia but sought to market it for dementia despite knowing it could be fatal for dementia patients. After the FDA warned against its use for dementia, Johnson & Johnson sales representatives allegedly told psychiatrists not to worry about patient deaths, claiming they wouldn't get caught. They also suggested diagnosing patients with "late onset schizophrenia" to conceal their actions. The speaker claims this diagnosis is false and nonexistent. As a result, the speaker states that one in nine nursing home patients in the US are currently misdiagnosed with late onset schizophrenia to hide the drug's use.

The speaker discusses the pharmaceutical industry and its problems. They explain that the industry has struggled to keep up with advancements in molecular biology and the changing face of capitalism. The speaker highlights how the industry has become powerful and profitable by increasing drug prices and creating "me too" drugs with slight variations to extend patents. They criticize the lack of transparency and the influence of the pharmaceutical industry on decision-making at international and national levels. The speaker emphasizes the need for better pharmacovigilance and the importance of educating doctors about the risks and benefits of medications. They also mention the need for better reporting and understanding of adverse effects. The speaker concludes by stating that changes are needed in medical education and the way medications are developed and prescribed.

The speaker admits to using babies of imprisoned mothers and individuals under colonial rule to study experimental vaccines, including in the Belgian Congo with almost a million people. Another speaker raises concerns about the safety of genetically modified organisms used in medicines and the practice of injecting them into children's arms. Safety testing and potential side effects are mentioned.

The speaker, a former pharmaceutical sales rep, shares their disillusionment with the industry after discovering corruption and falsified safety data. They recount their experience with vaccines and their concerns about the lack of rigorous safety studies and the toxic additives, such as aluminum, in childhood vaccines. The speaker highlights the high rates of illness in American children compared to other developed countries and attributes it to the profit-driven nature of the pharmaceutical industry. They discuss the influence of pharmaceutical companies on the media and the lack of liability for vaccine manufacturers. The speaker emphasizes the need for more research and information before mandating vaccines, citing the potential risks involved.

Fifteen percent of high schoolers are on Adderall, which was created by Merck in Nazi Germany to make German soldiers more aggressive. The drug was discontinued due to psychosis among soldiers, but Merck reformulated it into a stronger version, which is now Adderall. Parents are being pressured to put their kids on Adderall, just as they are with Ozempic, SSRIs, and SANs. Children in sedentary environments with limited sunlight, being fed ultra-processed food, are prescribed Adderall for being fidgety. This is mass child abuse, and it is being normalized.

The speaker discusses the pharmaceutical industry and its problems. They explain that the industry has struggled to keep up with the complexity of molecular biology and the changing face of capitalism. The speaker highlights how the industry has become powerful and profitable by increasing prices and creating "me too" drugs. They criticize the lack of transparency and the influence of the industry on decision-making at various levels. The speaker emphasizes the need for better pharmacovigilance and a change in medical education to prioritize understanding the dangers of medications. They also address concerns about the industry and the role of doctors.

Dr. Josef Duhring and Dr. Yosef (Doctor Yosef Duhring) discuss antidepressants and SSRIs, outlining perceived risks, data limitations, and long-term concerns, followed by practical guidance on tapering and contact information for a tapering clinic. Key side effects and risks cited - Common side effects: gastrointestinal issues (nausea, vomiting, diarrhea), changes in sleep (insomnia or drowsiness), headaches, nervousness, restlessness, dry mouth, sweating, tremors, sexual dysfunction, decreased libido, difficulty reaching orgasm, erectile dysfunction, appetite and weight changes (gain or loss). - Other reported effects: emotional blunting, feeling less like yourself, dizziness, balance issues (especially early in treatment), increased sweating, abnormal dreams. - Serious but rarer risks: suicidal thoughts or behaviors, particularly under age 25; serotonin syndrome (described as rare); heart rhythm changes at high doses with some SSRIs. - Behavioral effects: mania, psychosis, irritability, aggression; rare but potentially misdiagnosed as bipolar disorder; in some cases leading to escalation to lithium or antipsychotics. - Sleep and long-term effects: SSRI use diminishing sleep quality (less REM and deep sleep), resulting in fatigue and brain fog in long-term users. - Long-term data gaps: “there has never been a randomized control study that looked at them for over a year,” and “seventy percent of antidepressant users are on these drugs for two years or more.” Claims that there is no long-term data on sustained efficacy or safety beyond eight to twelve weeks. Efficacy and data concerns - Most drugs reach market based on eight-week studies; there is a reported two-point difference on a 52-point depression scale between the drug and placebo, which is described as clinically very low. - Outcomes most meaningful to patients (employment, relationships, life meaning) are not directly measured in standard trials, which focus on scale-based movement. - The claim is made that long-term efficacy remains unproven and that the long-term data are unavailable. Observations about prescription patterns and systemic factors - Online “pill mill” platforms allegedly enable easy access to SSRIs (Lexapro), sometimes without video chats, via online questionnaires, with rapid mail delivery. - The dose of prescription and patient interactions are affected by time constraints and economic incentives in healthcare delivery, leading to faster checklists and medication-based treatments rather than in-depth discussions of life context, relationships, or non-drug approaches. - An “unholy alliance” between the pharmaceutical industry and academic medicine is described: investigators may pursue drug trials for career advancement and publications funded by drug companies, potentially biasing conclusions in favor of medications. - The FDA’s stance is portrayed as influenced by this environment, with concerns about regulatory capture and inadequate critical evaluation of risks, including suicide risk data and withdrawal issues. Key long-term and withdrawal considerations - Long-term withdrawal: physicians are described as telling patients that antidepressant withdrawal is mild and resolves in two weeks, but tapering often requires one to two years to avoid withdrawal symptoms; many are tapered too quickly, leading to relapse or withdrawal challenges. - Tapers and recovery: the clinician reports patients improving emotionally during tapering, sometimes even before complete discontinuation; success depends on broader life health improvements (physical health, relationships, purpose) and careful, gradual reduction. Three major concerns observed with antidepressants (as described by Dr. Yosef) - They don’t work for many patients in the long term; diminished efficacy over time due to emotional blunting and neurochemical adaptation. - Behavioral and cognitive changes: potential for mania, psychosis, irritability, and misdiagnosis as bipolar disorder; risk of “drug-induced” psychiatric symptoms. - Toxicity and sleep: long-term blunting reduces emotional responsiveness; chronic sleep disruption and brain fog; long-term toxicity may underlie persistent symptoms after prolonged use. Clinical implications and guidance offered - For those considering antidepressants, emotions matter and should be explored beyond a chemical-imbalance narrative; discuss physical health, relationships, purpose, substances, and non-drug approaches (therapy, lifestyle changes) before relying on medication. - For those already on SSRIs, a careful, patient-guided taper is advised: slowly reduce dosages, use approaches such as liquid tapering to control precise reductions, and listen to one’s body to avoid withdrawal; a two-year taper may be necessary for many patients. - Coming off antidepressants can reveal or restore aspects of life and personality; benefits may appear during tapering as engagement and motivation return, but life circumstances must be addressed in parallel to avoid relapse. Contact information - Tapering clinic website: taperclinic.com (for patients in the U.S.; clinic claims to operate in about 15–16 states, covering roughly 70% of the population). - YouTube channel for further resources: Doctor Yosef (German version) with a free drug tapering training (about five hours) and guidance for working with a doctor. Speaker names - Dr. Yosef Duhring (referred to as Doctor Josef Duhring in the discussion) and Dr. Yosef (the same speaker) are cited; their experiences include FDA and industry roles and a tapering clinic specializing in antidepressant withdrawal and discontinuation.

The psychiatric and drug industries have a financial interest in each other's success. Psychiatric drugs are widely consumed in America, with one in five people taking psychoactive drugs. These drugs have adverse effects, including an increased risk of suicide and violence. Despite this, there is little outrage in the government and medical community about the connection between psychiatric drugs and school shootings. When investigating the cause of these shootings, the coroner's office refused to release information about the drugs involved, citing privacy concerns. However, the argument that withholding this information protects public health is unfounded. It is likely that the suppression of information is driven by the financial interests of the psychiatric and drug industries.

Speaker 0 describes a photo sent to Laura around Christmas last year: a 12-year-old boy with more than 50 pharmaceutical bottles in front of him, representing the prescriptions he took that year. The speaker asserts that this is about money, stating that the pharmaceutical industry and doctors aim to make children customers for life, and that if they can break children early, they give them asthma, allergies, eczema, ADD, ADHD, insulin-dependent diabetes, a long list of neurological problems, and cancers from an early age; all of those pills are the reason they do this. The speaker notes a correlation with POTS (postural orthostatic tachycardia syndrome) and links it to Gardasil and to the COVID shot, while saying it can be associated with other vaccines too because of Guillain-Barré syndrome. The speaker mentions that their daughter has Guillain-Barré syndrome. They reiterate that all of those pills, though not every child takes that many prescriptions, almost all have something—an inhaler, something for headaches, something for something—due to disruption of their immune system that happened when they were six, eight, or ten pounds old. The speaker emphasizes that this disruption is intentional and that this part is particularly sinister.

A person at a book signing told the speaker a story about Remdesivir. According to the story, a woman's sister was in the hospital when a doctor ordered a second round of Remdesivir. The nurse cautioned the doctor that the patient had four young children. The doctor then rescinded the order. The speaker claims this shows the doctor and nurse knew the drug was killing people, but spared the patient because she had children. The speaker believes that without children, the doctor would have administered the drug and killed her anyway. The speaker concludes this reflects the personalities, behaviors, and ethos of hospital staff.

I recently heard stories of people losing their children to Pfizer injections, some experiencing immediate or gruesome deaths. The FDA knew about potential risks like cancer from as far back as 2013, but suddenly in 2020, these concerns were ignored. This seems like a premeditated crime, with regulators aware of the dangers. Military involvement in pushing these products is suspicious.

There is a lot of corruption in politics due to money, bribes, and backdoor deals. One major mistake was allowing drug companies to advertise on television, which only two countries, the United States and New Zealand, permit. These commercials often make exaggerated claims and list potential side effects very quickly. It's concerning how they can make something seem great one moment and then mention serious side effects like suicidal thoughts and rectal bleeding. Personally, I haven't taken many medications, but when I tried SSRIs, I found the last 20 seconds of the commercial more impactful than the rest, and I didn't experience any benefits from them.

Since age 4, I've been on meds like Lexapro and Abilify that made me feel like a zombie. Foster care kids in the US are given powerful mind-altering drugs at a rate 13 times higher than other children. A GAO report reveals infants in foster care are given psychotropic drugs with unknown long-term effects. One case involved a 7-year-old on 5 risky medications. Foster parents are pressured to medicate or risk losing their child. The system profits from drugging vulnerable kids with expensive drugs.

The psychiatric and drug industries have a financial interest in each other's success. Psychiatric drugs are widely consumed in America, with 1 in 5 people using psychoactive drugs. However, these drugs have adverse effects, including an increased risk of suicide and violence. It is concerning that many school shooters have been on psychiatric drugs, which the FDA acknowledges can lead to such behaviors. When investigating the cause of these incidents, the coroner's office refused to release relevant information, citing privacy concerns. The assistant attorney general argued that disclosing this information could discourage people from taking their psychiatric medication, but this argument is flawed. The financial interests of the psychiatric and drug industries may be influencing the suppression of information and censorship. It is crucial to reconsider the use of these drugs, especially for children.

According to the speaker, 100% of documented school shootings in America over the past 52 years were committed by teenagers on either an antidepressant or a barbiturate drug for anxiety. The speaker claims that every antidepressant, including Prozac, Zoloft, and Xanax, as well as anti-anxiety drugs, are published to increase the risk of suicide, violent behavior, and homicidal actions. The speaker asserts that these drugs are prescribed by doctors and sold at pharmacies like CVS and Walgreens.

Only two countries worldwide allow pharmaceutical TV ads, including the U.S., where over a billion dollars monthly is spent. These ads convey that Americans frequently experience bowel and bladder issues, active seniors enjoy tennis and sex, and pills can solve any problem, even pill overuse. The speaker questions the need to suggest medications to doctors and highlights the growth of ketamine clinics in America. Western medicine, it's argued, treats respectable drugs differently from street drugs, despite similarities. Oxycodone is heroin, Adderall is meth, and Ritalin is cocaine for kids. Ketamine, once an illegal club drug, was FDA-approved as an anesthetic. The speaker suggests the first drug one uses is the gateway drug, be it beer, pot, or pharmaceuticals prescribed to children. Resisting profitable but harmful substances requires individual effort.

The speaker admits to using orphans and mentally handicapped individuals to study experimental vaccines in the 1960s, stating that it was a common practice at the time. They also acknowledge writing a letter expressing the belief that experiments should be performed on those less likely to contribute to society, such as children with disabilities. The speaker confirms using babies of mothers in prison and individuals under colonial rule in the Belgian Congo for vaccine studies, involving almost a million people. They mention changing their views since then.

Concerns arise about the influence of pharmaceutical companies on psychiatric diagnoses, particularly regarding child dysphoria. Children, who are not allowed to make significant decisions like getting tattoos or drinking alcohol, are being encouraged to change their gender. Studies on puberty blockers indicate they do not improve mental health and may have severe side effects, yet this information is not being published. There seems to be a cultural trend among certain demographics, particularly affluent white progressives, where identifying as trans becomes a social signifier. This shift may lead parents to rationalize their child's gender identity as a way to engage with social issues. Normal adolescent confusion is being medicalized, risking irreversible consequences for children who may later regret their decisions.

Drug companies are the wealthiest businesses and buy influence, including ministers of health. They target professors and chiefs of departments to become key opinion leaders who indoctrinate other doctors to use expensive drugs over cheaper alternatives. Medical education is partly corrupted. Doctors should avoid educational events funded by the drug industry, as key opinion leaders are selected for their sales abilities. Denmark is considered one of the least corrupt countries, but its healthcare system is corrupt. In Denmark, thousands of doctors are on drug company advisory boards or consult, which is how influence and loyalty are bought. Many of these doctors don't do much but are being bought.

Pharmaceutical companies like Merck, Sanofi, Pfizer, and Glaxo have paid billions in penalties for dishonest practices, resulting in harm and deaths. The opioid crisis and Vioxx are examples of collusion between pharma and regulators, leading to thousands of deaths. Regulatory agencies have become puppets for the industry, depriving the public of informed consent.

Most physicians and clinicians avoid getting involved in the issue of profit-driven healthcare. The real problem lies in the collusion between academic institutions, doctors, medical journals, and industry for financial gain. These corporations, as legal entities, often exhibit psychopathic traits, prioritizing profit over the well-being of patients. Many top drug companies have been fined billions for illegal marketing, hiding harm data, and manipulating results. However, these fines are often outweighed by the profits they make from selling the drugs. While the pharmaceutical industry has contributed life-saving treatments, the net effect of their practices is negative, with a significant amount of wasted resources and harmful drugs approved.

The speaker, who used to work in the pharmaceutical industry, criticizes the industry for prioritizing profit over people's health. He shares his own experiences of being involved in corruption and unethical practices. He highlights the lack of transparency and the influence of the industry on doctors and politicians. He also discusses the overprescription of medication to children, particularly psychotropic drugs, and the harmful effects they can have. The speaker calls for public awareness and action to hold the pharmaceutical industry accountable and protect the health of future generations.

The discussion traces a long, shadowy arc in the development of modern vaccines and medicine, arguing that rapid COVID-19 vaccine progress rests on over a century of influence by powerful interests rather than sudden breakthroughs. - The narrative centers on John D. Rockefeller, who became America’s first billionaire in 1913, the same year the Federal Reserve was created. It frames Rockefeller as leveraging his oil wealth to monopolize medicine, promoting prescription drugs while vilifying natural and holistic remedies. The claim is that Rockefeller used strategic philanthropy (Rockefeller Institute for Medical Research, established 1901; Rockefeller Foundation, 1913) to push laboratory-based, drug-centered medicine, marginalize herbalism and naturopathy, and steer doctors toward pharmaceuticals. The effect, according to the speakers, was to keep people sick so they would return for ongoing treatments rather than cures. - The timeline continues with the rise of the pharmaceutical industry from the 1920s to 1940s, described as moving into synthetic drugs with Rockefeller guidance. Natural remedies were said to be non-patentable while synthetic drugs could be patented, creating a business incentive for ongoing, chronic treatment rather than cures. - The conversation shifts to regulatory dynamics, arguing that regulation became regulatory capture from the 1930s to 1960s, with the FDA functioning as a gatekeeper increasingly populated by former pharma professionals. The FDA’s integrity is debated through the example of Dr. Francis Kelsey, who resisted approving thalidomide; the drug was later linked to birth defects worldwide, and Kelsey’s stance is presented as a rare early stand for public safety. - In the 1970s and 1980s, the narrative asserts growing corporate influence: pharma lobbies expand, advertising budgets explode, and medicine becomes a growth industry. The Bayh-Dole Act of 1980 is cited as enabling private patents on publicly funded research, tying universities to pharma interests and shaping medical education toward pharmaceutical solutions. Direct-to-consumer advertising is highlighted as a turning point in the 1990s, pressuring doctors through patient demand spurred by TV ads. - The discussion includes a first-hand account from a former pharmaceutical sales representative, Lisa Prada, who describes bribes and perks (golf outings, concerts, strip clubs, etc.) to influence prescribing, and asserts that patients were often treated as means to corporate ends. - Kim Bright, founder of Brightcore Nutrition, joins to discuss current health issues, arguing that the pharmaceutical industry prioritizes profits over patient well-being. She notes that the Rockefeller Foundation funded COVID-19 vaccine efforts (she cites $55 million) and argues the foundation and industry continued to push medical interventions globally. She notes that the FDA’s public acknowledgment of COVID vaccine-related child deaths is incongruent with whistleblowers’ claims and autopsy data. - The program underscores the idea that prescription drugs are the third leading cause of death in the United States and Europe, citing studies on gut microbiome disruption from medications like antibiotics and acid-reducing drugs (dysbiosis) as a major contributor to chronic disease. - The gut microbiome is emphasized as central to health. Dr. David Perlmutter’s work on the gut-brain connection is referenced, including criticism faced for linking diet and fermented foods to health outcomes. Kimchi is highlighted as a powerful antimicrobial and a potential anti-aging agent in cellular studies. The hosts discuss kimchi’s health benefits, including improved digestion, immune function, and weight management. - Brightcore promotes Kimchi One capsules as a convenient alternative for Americans who dislike traditional kimchi, claiming benefits such as reduced bloating, better digestion, improved hair and skin, and weight loss. A discount offer is advertised: 25% off online, up to 50% off with a phone order, free shipping, and a free vitamin D3 with the first 100 callers, using the code provided. - The conversation closes with reflections on the do-not-mistake-the-system dynamic, optimism about changes in medicine, and calls for removing dependency on processed foods and advertising-driven medicine, with an acknowledgment of RFK Jr.’s activism against pharmaceutical ads on television.